SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WorldFinancial

WLFI is trending amid significant community discussion ahead of a high-profile Mar-a-Lago forum where industry leaders are expected to convene. Speculation surrounds potential announcements for institutional adoption and Real World Asset tokenization, even as the crypto project faces ongoing congressional scrutiny regarding foreign investments and its connection to the Trump family.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending amid recent multi-million dollar orders for its Iron Drone Raider system from a NATO country and the deployment of its Sentrycs counter-UAS solution with German State Police. The community is actively discussing the company's continuous contract wins and strategic expansion in the burgeoning defense and counter-drone market, perceiving it as a rapidly growing player despite market volatility.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its recent earnings report showed robust revenue growth and increased guidance, yet a lowered EPS outlook fueled by acquisition-related costs sparked a sell-off. The community is debating if this is an overreaction stemming from broader software sector concerns and high valuations, or a logical repricing, even as many see long-term buying opportunities due to cybersecurity's non-discretionary nature and platform consolidation trends.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as its CEO expressed significant confidence in near-term commercial deals for MST, touting its potential for 40% power reduction in AI and next-gen GAA/DRAM chips, igniting community speculation about major licensing agreements or a buyout.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital (APLD) is trending after NVIDIA's recent 13F filing revealed an exit from its stake, leading many in the community to debate if the subsequent sell-off is an overreaction. Investors are emphasizing APLD's ongoing AI infrastructure buildouts and substantial long-term contracts, particularly with NVIDIA-backed CoreWeave, as unchanged fundamentals driving future growth.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as its ANKTIVA immunotherapy secured conditional marketing authorization from the EU, alongside positive regulatory discussions in Saudi Arabia to expand approvals for additional tumor types. The community is expressing strong bullish sentiment, driven by anticipation of global market expansion and high short interest suggesting potential for a significant squeeze.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amidst heightened discussions on its role in the "AI-Nuclear Nexus," fueled by broader sector tailwinds like major carbon-free data center investments and US government initiatives to accelerate nuclear deployment. While some investors are optimistic about potential regulatory approvals and significant partnerships, others remain cautious, citing the company's pre-revenue status and recent insider share sales as concerns, despite a technical bounce from key support levels.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy (PRO) is gaining traction for its blockchain- and AI-powered platform, aiming to revolutionize real estate transactions through tokenization and its 'Agent Avery' technology. The community is actively debating the project's long-term disruptive potential within the massive global real estate market, with many seeing its current valuation as significantly underpriced given recent strategic roadmap updates and anticipated on-chain property sales.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Domino's Pizza is trending as investors digest its latest mixed earnings, which highlighted robust sales driven by aggressive value promotions and new menu items, alongside sustained buying by Warren Buffett's Berkshire Hathaway. The community debates if these strategic moves and institutional backing can overcome broader macroeconomic headwinds and fierce restaurant competition.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following its FDA Fast Track designation for PPP, fueling discussions around significant institutional accumulation and a potential short squeeze. The community is eagerly anticipating its upcoming Investor Day for critical clinical data readouts and growing buyout speculation, believing the "best-in-class" nanobody drug is deeply undervalued despite perceived market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period

MRK outlines solid long-term outlook with more than $70B opportunity beyond Keytruda LOE, backed by pipeline progress, new product launches and M&A deals.

Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead?

PRTA stock declines 36.8% in a year as birtamimab's failure, earnings miss and reliance on partner programs weigh on investor confidence.

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down

Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.

Will Eylea Sales Decline Weigh on REGN's Top Line in 2026?

Regeneron foresees further Eylea decline in 2026 as biosimilars loom, but Eylea HD, Dupixent and Libtayo aim to steady revenues.

International ETFs to Watch as Foreign Stock Markets Beat the US

International stocks crushed U.S. markets in 2025, with ETFs such as SPDW and JIVE emerging as top plays on the global shift.

Here's What Will Drive AbbVie's Top-line Growth in 2026

ABBV sees 2026 revenues rising to $67B as Rinvoq and Skyrizi drive growth, with neuroscience gains offsetting Humira erosion and oncology headwinds.

BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View

Biogen tops Q4 earnings and sales estimates, and shares rise after the company issues an encouraging 2026 adjusted EPS outlook despite revenue pressure.

AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View

ABBV beats Q4 earnings and revenue estimates, but shares slip as Rinvoq and oncology sales miss expectations despite strong 2026 EPS guidance.

Novartis Beats on Q4 Earnings, Entresto Generics Pressure Sales

NVS tops Q4 EPS estimates as margins expand, but revenues miss the mark amid U.S. generics hitting Entresto and Promacta, reshaping its growth mix.

Buy AbbVie Stock Before Q4 Earnings? Here's What to Know

ABBV heads into Q4 earnings with Skyrizi and Rinvoq driving growth, Humira sales sliding, and shares trading at a discount to the industry.

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Roche Holding AG - ADR

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

RHHBY
Roche Holdings AG ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RHHBY News

RHHBYRoche Holdings AG ADR